HER2-L755S mutation induces hyperactive MAPK and PI3K-mTOR signaling, leading to resistance to HER2 tyrosine kinase inhibitor treatment
about
HER2-L755S mutation induces hyperactive MAPK and PI3K-mTOR signaling, leading to resistance to HER2 tyrosine kinase inhibitor treatment
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
HER2-L755S mutation induces hy ...... ine kinase inhibitor treatment
@en
type
label
HER2-L755S mutation induces hy ...... ine kinase inhibitor treatment
@en
prefLabel
HER2-L755S mutation induces hy ...... ine kinase inhibitor treatment
@en
P2093
P1433
P1476
HER2-L755S mutation induces hy ...... ine kinase inhibitor treatment
@en
P2093
P304
P356
10.1080/15384101.2019.1624113
P577
2019-06-03T00:00:00Z